Alle verbonden artikelen

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.

Auteurs : Poirel HA, Vanspauwen M, Macq G, De Geyndt A, Maertens J, Willems E, Selleslag D, Poiré X, Theunissen K, Graux C, Kerre T, Zachée P, Meuleman N, De Becker A, Verlinden A, Van Obbergh F, Schuermans C, de Wilde V, Jaspers A, Pranger D, Deeren D, van Riet I, Vaes E, Beguin Y
Jaar : 2019
Journal : Bone Marrow Transplant
Volume : 54
Pagina's : 1434-1442

Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Auteurs : Giraud C, Thibert JB, Desbrosses Y, Debiol B, Alsuliman T, Bardiaux L, Garban F, Huynh Thi, Samsonova O, Yakoub-Agha I, Bruno B
Jaar : 2019
Journal : Bull Cancer
Volume : 106
Pagina's : S52-S58

Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells.

Auteurs : Najar M, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2019
Journal : Cytotechnology
Volume : 71
Pagina's : 375-388

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o

Auteurs : Dieci MV, Radosevic-Robin N, Fineberg S, Van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, DAlfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, Singh B, Nielsen T, Viale G, Kim SR, Hewitt S, Wienert S, Loibl S, Rimm D, Symmans F, Denkert C, Adams S, Loi S, Salgado R
Jaar : 2018
Journal : Semin Cancer Biol
Volume : 52
Pagina's : 16-25

A gene signature to predict high tumour-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple negative breast cancer.

Auteurs : Criscitiello C, Bayar MA, Curigliano G, Symmans FW, Desmedt C, Bonnefoi H, Sinn B, Pruneri G, Vicier C, Pierga JY, Denkert C, Loibl S, Sotiriou C, Michiels S, André F
Jaar : 2018
Journal : Ann Oncol
Volume : 29(1)
Pagina's : 162-169

The Micronome of Mesenchymal Stromal Cells is partially responsive to Inflammation.

Auteurs : Fayyad-Kazan H, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Jaar : 2018
Journal : Cell Biol Int
Volume : 42(2)
Pagina's : 254-260

White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection.

Auteurs : Compté N, Dumont L, Bron D, De Breucker S, Praet JP, Bautmans I, Pepersack T
Jaar : 2018
Journal : Exp Gerontol
Volume : 114
Pagina's : 87-92

Monoclonal gammopathy of undetermined significance : when and why to look for them ?

Auteurs : Meuleman N, Vercruyssen M
Jaar : 2018
Journal : Rev Med Brux
Volume : 39
Pagina's : 302-306

Malignant or benign hyperleukocytosis ?

Auteurs : Spilleboudt C, Thibaut P, Varlet E, Bron D
Jaar : 2018
Journal : Rev Med Brux
Volume : 39
Pagina's : 291-295

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Auteurs : Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N
Jaar : 2018
Journal : Blood
Volume : 132
Pagina's : 2456-2464

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays.

Auteurs : Jose V, Fumagalli D, Rothé F, Majjaj S, Loi S, Michiels S, Sotiriou C
Jaar : 2018
Journal : PLoS One
Volume : 13
Pagina's : e0203346

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning.

Auteurs : Klauschen F, Müller KR, Binder A, Bockmayr M, Hägele M, Seegerer P, Wienert S, Pruneri G, de Maria S, Badve S, Michiels S, Nielsen TO, Adams S, Savas P, Symmans F, Willis S, Gruosso T, Park M, Haibe-Kains B, Gallas B, Thompson AM, Cree I, Sotiriou C, Solinas C, Preusser M, Hewitt SM, Rimm D, Viale G, Loi S, Loibl S, Salgado R, Denkert C
Jaar : 2018
Journal : Semin Cancer Biol
Volume : 52
Pagina's : 151-157

The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results of a multicenter study.

Auteurs : Stamatopoulos B, Smith T, Crompot E, Pieters K, Clifford R, Mraz M, Robbe P, Burns A, Timbs A, Bruce DR, Hillmen P, Meuleman N, Mineur P, Firescu R, Maerevoet M, de Wilde V, Efira AA, Philippé J, Verhasselt B, Offner F, Sims D, Heger A, Dreau H, Schuh A
Jaar : 2018
Journal : Clin Cancer Res
Volume : 24(20)
Pagina's : 5048-5057

Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation.

Auteurs : Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D
Jaar : 2018
Journal : Rev Med Brux

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium.

Auteurs : Kenis C, Decoster L, Flamaing J, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, Van den Bulck H, Goeminne JC, Schrijvers D, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lobelle JP, Lycke M, Milisen K, Wildiers H
Jaar : 2018
Journal : Ann Oncol
Volume : 29
Pagina's : 1987-1994

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Auteurs : Rossi C, Gilhodes J, Maerevoet M, Herbaux C, Morschhauser F, Brice P, Garciaz S, Borel C, Ysebaert L, Obéric L, Lazarovici J, Deau B, Dupuis J, Chauchet A, Abraham J, Bijou F, Stamatoullas-Bastard A, Malfuson JV, Golfier C, Laurent C, Pericart S, Traverse-Glehen A, Kanoun S, Filleron T, Casasnovas RO, Ghesquières H
Jaar : 2018
Journal : Am J Hematol

Are we ready for intercultural cancer care?

Auteurs : Crombez P, Michiels S, Bron D
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 205-211

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).

Auteurs : Rahmé R, Ades L, Thomas X, Guerci-Bresler A, Pigneux A, Vey N, Raffoux E, Castaigne S, Spertini O, Wittnebel S, Marolleau JP, Damaj G, Bordessoule D, Lejeune J, Chevret S, Fenaux P
Jaar : 2018
Journal : Haematologica
Volume : 103
Pagina's : e519-e521

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation.

Auteurs : Fostier K, Caers J, Meuleman N, Broos K, Corthals J, Thielemans K, Schots R, De Keersmaecker B
Jaar : 2018
Journal : Oncotarget
Volume : 9
Pagina's : 20476-20489

Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Auteurs : Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D
Jaar : 2018
Journal : Eur J Haematol
Volume : 101
Pagina's : 415-417